Vertically Integrated Company Developing Science-Driven Cannabinoid Biopharmaceuticals

Developing science-driven synthetic cannabinoid therapies while driving innovation in the endocannabinoid space

Ir
Message: Stock Day Podcast Interviews CEO of Applied Biosciences to Discuss Near-Term Growth Expansion Strategy

Stock Day Podcast Interviews CEO of Applied Biosciences to Discuss Near-Term Growth Expansion Strategy

posted on Oct 01, 2019 09:01AM

The Stock Day Podcast welcomed Applied BioSciences Corp. (OTCQB: APPB) ("the Company") CEO, Raymond Urbanski, M.D. for an interview with Stock Day host, Everett Jolly. During the interview, Dr. Urbanski discussed the Company's progress with building a robust pipeline within its BioPharma division; the growth witnessed and further development of its marketing and eCommerce capabilities for the Company's Applied Products division; and the expected plans to unlock value with Trace, the Company's Analytics Division.

To hear Dr. Urbanski's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7384239-the-stock-day-podcast-interviews-ceo-of-applied-biosciences-to-discuss-near-term-growth-expansion

Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/

About Applied BioSciences Corp.

Applied BioSciences is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. We also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to our customers. For more information, visit the Company's website.

Share
New Message
Please login to post a reply